Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006
Arterial hypertension in patients with obstructive sleep apnoea and overlap syndrome Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009
Evaluation of thyroid function in patients with suspected obstructive sleep apnoea syndrome Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010
Impact of pulmonary hypertension on reduction of right ventricular longitudinal strain in patients with obstructive sleep apnea syndrome Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies Year: 2015
Prevalence of obstructive sleep apnea among patients with resistant arterial hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 115s Year: 2005
Treatment control in risk patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 411s Year: 2006
Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008
Pulmonary hypertension and obstructive sleep apnea syndrome -Marmara Universitypediatric sleep laboratory experience Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new? Year: 2020
Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009
Non invasive ventilation versus continuous positive airway pressure in patients with obstructive sleep apnea syndrome and chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 546s Year: 2004
Unrecognised systemic hypertension in patients with obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 643s Year: 2006
The lymphocyte subset analysis in patients with arterial hypertension and severe obstructive sleep apnea syndrome Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019
Arterial hypertension in patients with obstructive sleep apnea syndrome in cluj napoca, Romania Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009
Pericardial effusion in patients with obstructive sleep apnea syndrome without daily hypoxemia and pulmonary arterial hypertension Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders Year: 2016
Unrecognised hypertension in patients screened for obstructive sleep apnoea Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005
Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients. Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019
Day time pulmonary hypertension in patients with obstructive sleep apnea hypopnea syndrome Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008
High prevalence of sleep apnea syndrome and systemic hypertension at patients with acromegaly Source: Annual Congress 2010 - The upper airway and oral appliances Year: 2010
Resistant arterial hypertension and obstructive sleep apnea syndrome Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012